| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327294 | Gynecologic Oncology | 2005 | 7 Pages |
Abstract
The absence of progesterone receptors may relate to the failure of progestin treatment. The use of progestin treatment for well-differentiated early endometrial carcinoma should be cautious and requires very careful clinical evaluation before and after treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Yuh-Cheng Yang, Chao-Chih Wu, Chie-Pein Chen, Chih-Long Chang, Kung-Liang Wang,